A Case of Hepatocellular Carcinoma with Pulmonary Metastasis Who Showed Complete Response by Cytotoxic Chemotherapy after Sorafenib Failure
Journal of Liver Cancer
; : 72-76, 2017.
Article
em Ko
| WPRIM
| ID: wpr-156766
Biblioteca responsável:
WPRO
ABSTRACT
Hepatocellular carcinoma (HCC) is the 2nd most common cause of cancer related death in Korea and well-known malignancy with poor prognosis. Sorafenib is the first-line molecular targeted agent in patients with extra-hepatic spread of HCC. However, complete response is extremely rare in patients treated with sorafenib and the disease control rate is only 43%. We report a 53-year-old man with advanced HCC with pulmonary metastasis who showed complete response by cytotoxic chemotherapy with doxorubicin and cisplatin with relatively tolerable adverse effects after failure of treatment with sorafenib.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Prognóstico
/
Doxorrubicina
/
Cisplatino
/
Carcinoma Hepatocelular
/
Tratamento Farmacológico
/
Coreia (Geográfico)
/
Metástase Neoplásica
Tipo de estudo:
Prognostic_studies
Limite:
Humans
País/Região como assunto:
Asia
Idioma:
Ko
Revista:
Journal of Liver Cancer
Ano de publicação:
2017
Tipo de documento:
Article